23 unknown. 23 Phase 3, 3 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 23 | Unknown 23 |
| Phase 2 | 3 | Unknown 3 |
Follow Glaucoma: new trials by email Literature Review of Glaucoma trials Research Report on Glaucoma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Travoprost Intraocular Implant in Conjunction With Cataract Surgery iDose TR - Open Angle Glaucoma, Ocular Hypertension | Phase 3 | Unknown | Glaukos Corporation | 60 | 2023-09-11 | 2024-06-03 |
| Prospective, Double-masked, Randomized, Multi-center, Active-controlled, Parallel-group, 3-month Study Assessing the Safety & Ocular Hypotensive Efficacy of TC-002 Ophthalmic Solution Compared to Latanoprost Ophthalmic Solution 0.005% in Subjects With Elevated Intraocular Pressure Latanoprost ophthalmic solution, 0.005%, TC-002 latanoprost ophthalmic solution, 0.005% - Elevated Intraocular Pressure | Phase 3 | Unknown | TearClear Corp | 300 | 2021-11-29 | 2022-05-25 |
| A Study of Efficacy and Safety of PHP-201 in Patients With Primary Open Angle Glaucoma or Ocular Hypertension Placebo ophthalmic solution, PHP-201 ophthalmic solution - Primary Open Angle Glaucoma, Ocular Hypertension | Phase 3 | Unknown | pH Pharma | 110 | 2021-11-01 | 2021-06-18 |
| Ahmed Valve Implantation Coated With Poly Lactic -Co-glycolic Acid (PLGA) Saturated With Mitomycin-C in the Management of Adult Onset Glaucoma in Sturge Weber Syndrome Ahmed Valve - Glaucoma | Phase 3 | Unknown | Sohag University | 10 | 2021-10-15 | 2022-04-06 |
| A Clinical Study to Evaluate the Efficacy and Safety of CKD-351 CKD-351, Latanoprost, D930 - Primary Open-angle Glaucoma, Ocular Hypertension | Phase 3 | Unknown | Chong Kun Dang Pharmaceutical | 384 | 2018-12-07 | 2018-12-03 |
| Trial of Aganirsen in iCRVO Patients at Risk of Developing NVG aganirsen - Ischaemic Central Retinal Vein Occlusion, Neovascular Glaucoma | Phase 2 / Phase 3 | Unknown | Gene Signal SAS | 333 | 2017-01-01 | 2016-10-31 |
| Intravitreal Ranibizumab (Lucentis®) for Neovascular Glaucoma- a Randomized Controlled Study Intravitreal ranibizumab - Glaucoma, Neovascular, Ranibizumab | Phase 3 | Unknown | LEANDRO CABRAL ZACHARIAS | 28 | 2016-10-01 | 2016-09-27 |
| Bleb Function and Morphology With Intratendon Injection of MMC Compared With Standard Method MMC - Glaucoma | Phase 3 | Unknown | Shahid Beheshti University of Medical Sciences | 126 | 2014-12-01 | 2015-03-11 |
| A Trial to Compare the Laser Treatment (SLT vs. ALT) in Glaucoma Patients Argon laser trabeculoplasty, Selective laser trabeculoplasty - Glaucoma | Phase 3 | Unknown | London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's | 139 | 2012-11-01 | 2018-03-06 |
| Switching From Preserved to Preserved-free Treatments for Glaucoma. Tafluprost, Latanoprost - Glaucoma | Phase 3 | Unknown | Paolo Fogagnolo | 40 | 2012-05-01 | 2014-05-16 |
| MIGS VS SLT Comparison in Glaucoma Patients MIGS Hydrus Ivantis, 360 degrees SLT - Glaucoma | Phase 3 | Unknown | University of Turin, Italy | 56 | 2012-02-01 | 2015-07-30 |
| Evaluation of Efficacy and Safety of Susanna Implant in Patients With Refractory Glaucoma. Susanna Implant - Glaucoma | Phase 3 | Unknown | Adapt Produtos Oftalmológicos Ltda. | 76 | 2011-05-01 | 2011-05-10 |
| Investigating the Neuroprotective Effect of Cop-1 (Copaxone) in Acute Primary Angle Closure Copaxone, Placebo (buffered normal saline w/v) - Glaucoma, Angle-closure, Primary, Acute | Phase 3 | Unknown | Singapore Eye Research Institute | 196 | 2010-09-01 | 2013-09-06 |
| Ahmed Valve Glaucoma Implant With Adjunctive Subconjunctival Bevacizumab in Refractory Glaucoma Subconjunctival Avastin, Ahmed Valve implant - Refractory Glaucoma | Phase 3 | Unknown | Vanak Eye Surgery Center | 40 | 2010-05-01 | 2010-05-24 |
| The Effect of Bevacizumab on the Trabeculectomy intraocular injections of bevacizumab - Glaucoma | Phase 2 / Phase 3 | Unknown | Samsung Medical Center | 40 | 2010-03-01 | 2010-05-26 |
| Intraocular Pressure (IOP) Lowering Effect of Selective Laser Trabeculoplasty Versus Prostaglandin Analogues in Angle Closure Glaucoma Selective Laser Trabeculoplasty, Travoprost/ Timolol/ Azopt/ Brimonidine - Glaucoma | Phase 3 | Unknown | Singapore Eye Research Institute | 90 | 2009-06-01 | 2010-05-12 |
| Goniocurettage as First Choice of Surgical Treatment in Chronic Open-Angle Glaucoma: Outcomes and Complications Goniocurettage - Open-Angle Glaucoma, Surgery | Phase 2 / Phase 3 | Unknown | Federal University of Minas Gerais | 32 | 2009-06-01 | 2012-01-18 |
| Oculusgen (Ologen) Collagen Matrix Implant for Phaco-Trabeculectomy in Primary Glaucoma: A Case-Control Study ologen™ Collagen Matrix Implant as an aid in phacotrabeculectomy surgery - Cataract, Glaucoma | Phase 3 | Unknown | Pro Top & Mediking Company Limited | 20 | 2007-12-01 | 2008-06-18 |
| Argon Laser Peripheral Iridoplasty for Primary Angle Closure Glaucoma Argon Laser Iridoplasty, Travatan/ Timolol/Azopt - Glaucoma | Phase 3 | Unknown | Singapore National Eye Centre | 80 | 2007-09-01 | 2011-06-17 |
| Ologen(Oculusgen)-Glaucoma and Pterygium Historical Control Study in China Shanghai Sixth People's Hospital ologen™ Collagen matrix implantation in glaucoma filtering surgery - Glaucomas, Pterygium | Phase 3 | Unknown | Pro Top & Mediking Company Limited | 60 | 2007-02-01 | 2011-10-07 |
Showing 20 of 23. Sign in to see all of them.
Glaucoma, Open-Angle (7) · Ocular Hypertension (4) · Glaucoma, Neovascular (3) · Cataract (1) · Glaucoma, Angle-Closure (1) · Pterygium (1)
Eye Diseases (23) · Ocular Hypertension (19) · Conjunctival Diseases (1) · Lens Diseases (1)
Latanoprost (2) · Timolol (2) · Trabeculectomy (2) · Travoprost (2) · brinzolamide (2) · Adrenergic beta-Antagonists (1) · Betaxolol (1) · Brimonidine Tartrate (1) · Coat Protein Complex I (1) · GS 101 (1) · Glatiramer Acetate (1) · Ranibizumab (1) · sovesudil (1) · tafluprost (1)
National Eye Institute (NEI) (3) · Pro Top & Mediking Company Limited (2) · Singapore Eye Research Institute (2) · Adapt Produtos Oftalmológicos Ltda. (1) · Chong Kun Dang Pharmaceutical (1) · Federal University of Minas Gerais (1) · Gene Signal SAS (1) · Glaukos Corporation (1) · LEANDRO CABRAL ZACHARIAS (1) · London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's (1) · Paolo Fogagnolo (1) · Samsung Medical Center (1) · Shahid Beheshti University of Medical Sciences (1) · Singapore National Eye Centre (1) · Sohag University (1)
Singapore (4) · South Korea (3) · Brazil (2) · Iran (2) · Italy (2) · United States (2) · Armenia (1) · Canada (1) · China (1) · Egypt (1) · Sweden (1)
Antonio Fea, MD (1) · Augusto Paranhos, Investigator (1) · Aung Tin, PhD MD (1) · Changwon Kee, M.D., Ph.D (1) · Hany Mahmoud, MD (1) · KiHo Park (1) · Luca Rossetti, MD (1) · Qiang Wu, MD (1) · Remo Susanna, Investigator (1) · Renato Lisboa, Investigator (1) · Sebastiao Cronemberger, PhD (1)
PMID 35943114, PMID 10937547, PMID 19152871, PMID 21467178, PMID 21843876, PMID 24727262, PMID 24906863, PMID 25429421, PMID 25893514, PMID 27450828, PMID 28100482, PMID 28302155, PMID 28408039, PMID 30278197, PMID 37010901, PMID 39959854
2014 (1)